Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent

American Heart Journal

Volumn 153, Issue 3, 2007, Pages 354-359

  Cosgrave, John ^a   Melzi, Gloria ^b   Corbett, Simon ^a   Biondi Zoccai, Giuseppe G L ^c   Babic, Rade ^a   Airoldi, Flavio ^b   Chieffo, Alaide ^b   Sangiorgi, Giuseppe M ^a   Montorfano, Matteo ^b   Michev, Iassen ^b   Carlino, Mauro ^b   Colombo, Antonio ^a,b  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Abano Terme Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVASCULARIZATION; RISK; STENT RESTENOSIS; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; PROSTHESIS DESIGN; RETREATMENT; SIROLIMUS; STENTS;

EID: 33847334760     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.12.009     Document Type: Article

References (24)

1. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized trial. JAMA 294 (2005) 1268-1270
4. Cosgrave J., Agostoni P., Ge L., et al. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. Am J Cardiology 96 (2005) 1663-1668
5. Lemos P.A., vanMieghem C.A., Arampatzis C.A., et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention. Late angiographic and clinical outcomes. Circulation 109 (2004) 2500-2502
6. Huang S., Bjornsti M.A., and Houghton P.J. Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther 2 (2003) 222-232
7. Richardson A., and Kaye S.B. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance. Drug Resist Updat 8 (2005) 311-321
8. Ahn C.M., Park S., Hong J.A., et al. Association of the polymorphism in the drug transporter gene ABCB1 with in-stent restenosis of paclitaxel eluting stents in the Korean subjects. (abstr). J Am Coll Cardiol 47 Suppl B (2006) 22B
9. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
10. Orlic D., Bonizzoni E., Stankovic G., et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 43 (2004) 1154-1160
11. Lansky A.J., Dangas G., Mehran R., et al. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol 39 (2002) 274-280
12. Hosmer D.W., and Lemeshow S. Applied logistic regression. 2nd ed. (2000), Wiley-Interscience, New York 143-202
13. Rubin D.B. Estimating causal effects from large data-sets using propensity scores. Ann Intern Med 127 (1997) 757-763
14. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
15. Cosgrave J., Melzi G., Biondi-Zoccai G.L., et al. Drug-eluting stent restenosis: the pattern predicts the outcome. J Am Coll Cardiol 47 (2006) 2399-2404
16. Colombo A., Orlic D., Stankovic G., et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107 (2003) 2178-2180
17. Popma J.J., Leon M.B., Moses J.W., et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 110 (2004) 3773-3780
18. Iakovou I., Schmidt T., Ge L., et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. J Am Coll Cardiol 45 (2005) 805-806
19. Corbett S.J., Cosgrave J., Melzi G., et al. Patterns of restenosis after drug-eluting stent implantation: insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Eur Heart J 27 (2006) 2330-2336
20. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2154-2156
21. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
22. Moussa I., Moses J.W., Kuntz R.E., et al. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). Am J Cardiol 97 (2006) 1582-1584
23. Lee S.S., Price M.J., Womg G.B., et al. Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure. Am J Cardiol 98 (2006) 1345-1348
24. Shelton M., Moore A., Shelton M.C., et al. Treatment of in-stent restenosis in drug eluting stents: have stent sandwiches solved the problem?. (abstr). J Am Coll Cardiol 47 Suppl B (2006) 44B